KarenEAndersonMD

PubMed

• Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
  David Stamler, Hadas Barkay, Amanda Wilhelm, Jessica K Alexander, Nayla Chaijale, Steve Barash, Juha-Matti Savola, Samuel Frank, Karen E Anderson, Hubert H Fernandez, ...> ;Neurology and Therapy. 2024 Apr 1
• Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease.
  Weintraub, D., Marras, C., Amara, A., Anderson, K., Chahine, L., Eberly, S., Hosamath, A., Kinel, D., Mantri, S., Mathur, S., Oakes, D., Purks, J., Standaert, D., Shou...> ;Movement Disorders. 2024 Feb 6
• 1 citations
  Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study.
  Reilmann, R., Anderson, K., Feigin, A., Tabrizi, S., Leavitt, B., Stout, J., Piccini, P., Schubert, R., Loupe, P., Wickenberg, A., Borowsky, B., Rynkowski, G., Volkins...> ;The Lancet. Neurology. 2024 Mar 1
• 1 citations
  What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP).
  Connie Marras, Lakshmi Arbatti, Abhishek Hosamath, Amy Amara, Karen E Anderson, Lana M Chahine, Shirley Eberly, Dan Kinel, Sneha Mantri, Soania Mathur, David Oakes, Je...> ;Journal of Parkinson's Disease. 2023 Jan 1
• 1 citations
  Death Anxiety in Huntington Disease: Longitudinal Heath-Related Quality-of-Life Outcomes.
  Leonard L Sokol, Jonathan P Troost, Danny Bega, Jane S Paulsen, Benzi M Kluger, Allison J Applebaum, Samuel Frank, Martha A Nance, Karen E Anderson, Joel S Perlmutter,...> ;Journal of Palliative Medicine. 2023 Jul 1
• Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptoms.
  Chahine, L., Arbatti, L., Hosamath, A., Amara, A., Anderson, K., Purks, J., Eberly, S., Kinel, D., Mantri, S., Mathur, S., Oakes, D., Standaert, D., Weintraub, D., Sho...> ;Clinical Parkinsonism & Related Disorders. 2023 Jan 1
• 2 citations
  Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.
  Karen E Anderson, Max Stevenson, Rency Varghese, Michaeline L Hebron, Erin Koppel, Mara McCartin, Robin Kuprewicz, Sara Matar, Dalila Ferrante, Charbel Moussa> ;Metabolites. 2022 Dec 6
• 1 citations
  The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease.
  Hilda T Maibach, Michael J Brownstein, Steven M Hersch, Karen E Anderson, Debra E Itzkowitz, Eve M Damiano, Neal G Simon> ;Journal of Personalized Medicine. 2022 Sep 22
• 5 citations
  Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects.
  Daisy Abreu, Jennifer Ware, Nellie Georgiou-Karistianis, Blair R. Leavitt, Cheryl Fitzer-Attas, Raquel Lobo, Ana Raquel Fernandes, Olivia J. Handley, Karen E. Anderson...> ;Frontiers in Neurology. 2021 Jan 1
• 10 citations
  Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
  Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach, Merit Cudkowicz, Christopher S. Coffey, Robin Conwit, Codrin Lungu, Karen E. Ande...> ;Journal of Clinical Medicine. 2020 Nov 16
• 34 citations
  Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.
  Hubert H. Fernandez, David Stamler, Mat D. Davis, Stewart A. Factor, Robert A. Hauser, Joohi Jimenez-Shahed, William G. Ondo, L. Fredrik Jarskog, Scott W. Woods, Danny...> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2019 Dec 1
• 11 citations
  The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.
  Karen E. Anderson, Shirley Eberly, Karen Marder, David Oakes, Elise Kayson, Anne B. Young, Ira Shoulson> ;Clinical Genetics. 2019 Jul 1
• 6 citations
  Quality of Care for Huntington's Disease in the United States: Findings from a National Survey of Patients and Caregivers.
  Karen E. Anderson, Jack Griffin, Al Kinel, Abdul R Shaikh, Temitope Olofintuyi, Stevan Ramirez, Joni Steinman, George J. Yohrling, Shari Kinel> ;Journal of Huntington's Disease. 2019 Jan 1
• 1 citations
  The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.
  Elise Kayson, Shirley Eberly, Karen E. Anderson, Karen Marder, Ira Shoulson, David Oakes, Anne B. Young, Kevin Biglan, Steven M. Hersch> ;Journal of Huntington's Disease. 2019 Jan 1
• 16 citations
  Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States
  Eileen Mack Thorley, Ravi Iyer, Paul Wicks, Christopher Curran, Sanjay Gandhi, Victor Abler, K Anderson, Noelle E. Carlozzi> ;The Patient. 2018 Oct 1
• 8 citations
  Huntington's Disease and Employment: The Relative Contributions of Cognitive and Motor Decline to the Decision to Leave Work.
  Kristen Watkins, Jennifer L. Purks, Anagha Kumar, Rosemary K. Sokas, Hope Heller> ;Journal of Huntington's Disease. 2018 Jan 1
• 120 citations
  Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.
  Karen E. Anderson, David Stamler, Mat D. Davis, Stewart A. Factor, Robert A. Hauser, Jouko Isojärvi, L. Fredrik Jarskog, Joohi Jimenez-Shahed, Rajeev Kumar, Joseph P. ...> ;The Lancet. Psychiatry. 2017 Aug 1
• 106 citations
  Randomized controlled trial of deutetrabenazine for tardive dyskinesia the ARM-TD study
  Hubert H. Fernandez, Stewart A. Factor, Robert A. Hauser, Joohi Jimenez-Shahed, William G. Ondo, L. Fredrik Jarskog, Herbert Y. Meltzer, Scott W. Woods, Danny Bega, Ma...> ;Neurology. 2017 May 23
• Response to letter by Saenz‐Farret et al. on “Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations”
  Tiago A. Mestre, Erik van Duijn, Aileen M. Davis, Anne-Catherine Bachoud-Lévi, Monica Busse, Karen E. Anderson, Cristina Sampaio, Christopher G. Goetz, Esther Cubo, Gl...> ;Movement Disorders. 2017 Mar 1
• 119 citations
  Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
  Georg Bernhard Landwehrmeyer, Cheryl Fitzer-Attas, J Giuliano, Nilza Gonçalves, Karen E. Anderson, Francisco Ferreira Cardoso, Joaquim J. Ferreira, Tiago A. Mestre, Ju...> ;Movement Disorders Clinical Practice. 2017 Mar 1
• 3 citations
  Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers
  Christina G. Perry, Katherine Holmes, Ann L. Gruber-Baldini, Karen E. Anderson, Lisa M. Shulman, William J. Weiner, Stephen G. Reich> ;Movement Disorders Clinical Practice. 2017 Jan 1
• 12 citations
  Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease.
  Karen E. Anderson, Shirley Eberly, Mark Groves, Elise Kayson, Karen Marder, Anne B. Young, Ira Shoulson> ;Journal of Huntington's Disease. 2016 Dec 15
• 6 citations
  Does spouse participation influence quality of life reporting in patients with Parkinson’s disease?
  Chelsea D. Morrow, Katherine Smentkowski, Stacy Schwartz, Melissa J. Armstrong, Ann L. Gruber-Baldini, Karen E. Anderson, Stephen G. Reich, William J. Weiner, Lisa M. ...> ;Quality of Life Research. 2015 Jan 1
• 166 citations
  Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
  Erik van Duijn, David Craufurd, Anna A.M. Hubers, Erik J. Giltay, Raphael M. Bonelli, Hugh Rickards, Karen E. Anderson, Marleen R. van Walsem, Rose C. van der Mast, Mi...> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2014 Dec 1
• 40 citations
  Dual task performance in Parkinson's disease: a sensitive predictor of impairment and disability.
  Rebecca L. Fuller, Elizabeth P. Van Winkle, Karen E. Anderson, Ann L. Gruber-Baldini, Terra Hill, Cris Zampieri, William J. Weiner, Lisa M. Shulman> ;Parkinsonism & Related Disorders. 2013 Mar 1
• Join now to see all

Journal Articles

• The effects of gait impairment with and without freezing of gait in Parkinson's disease  
  Josiah AF, Gruber-Baldini AL, Anderson KE et al, Parkinsonism Relat Disord, 1/1/2012
• Randomized Clinical Trial of 3 Types of Physical Exercise for Patients With Parkinson Disease  
  Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K Anderson KE, et al, Arch Neurol, 1/1/2012
• Assessment of Cognitive Symptoms in Prodromal and Early Huntington Disease  
  Vaccarino AL, Sills T, Anderson KE et al, PLoS Curr, 1/25/2011
• Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease  
  Vaccarino AL, Sills T, Anderson KE, et al, PLoS Curr, 1/17/2011
• Assessment of motor symptoms and functional impact in prodromal and early huntington disease  
  Vaccarino AL, Sills T, Anderson KE, et al, PLoS Curr, 1/14/2011
• Assessment of Day-to-Day Functioning in Prodromal and Early Huntington Disease  
  Vaccarino AL, Sills T, Anderson KE et al, PLoS Curr, 1/12/2011
• Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions"  
  Vaccarino AL, Anderson KE, Borowsky B et al, PLoS Curr, 1/11/2011
• Anxiety and self-perceived health status in Parkinson's disease  
  Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L, Parkinsonism Relat Disord, 1/1/2011
• Racial and socioeconomic disparities in parkinsonism  
  Hemming JP, Gruber-Baldini AL, Anderson KE, et al, Arch Neurol, 1/1/2011
• Huntington's disease  
  Anderson KE, Handb Clin Neurol, 1/1/2011
• Comorbidities of obsessive and compulsive symptoms in Huntington's disease  
  Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS, Huntington's Study Group, J Nerv Ment Dis, 1/1/2010
• Metoclopramide Induced Encephalopathy in Parkinson's Disease  
  Robottom BJ, Shulman LM, Anderson KE, Weiner WJ, South Med J, 1/1/2010
• Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease  
  Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L, Mov Disord, 1/15/2009
• Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease  
  Gruber-Baldini AL, Ye J, Anderson KE, Shulman LM, Parkinsonism Relat Disord, 1/9/2009
• The evolution of disability in Parkinson disease  
  Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, Weiner WJ, Mov Disord, 1/30/2008
• Mutuality of the marital relationship in Parkinson's disease  
  Tanji H, Anderson KE, Gruber-Baldini AL,et al, Mov Disord, 1/1/2008
• A comparative study of physical performance measures in Parkinson's disease  
  Tanji H, Gruber-Baldini AL, Anderson KE, et al, Mov Disord, 1/1/2008
• Psychogenic camptocormia  
  Skidmore F, Anderson KE, Fram D, Weiner W, Mov Disord, 1/15/2007
• Impact of Psychogenic Movement Disorders versus Parkinson's on Disability, Quality of Life and Psychopathology  
  Anderson KE, Ann L. Gruber-Baldini, Christopher G. Vaughan, Stephen G. Reich, Paul S. Fishman, William J. Weiner, Lisa M. Shulman, Mov Disord, 1/15/2007
• Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study  
  Anderson KE, Brickman AM, Flynn J, Scarmeas N, Van Heertum R, Sackeim H, Marder KS, Bell K, Moeller JR, Stern Y, Neurology, 1/3/2007
• Probability of Obsessive and Compulsive Symptoms in Huntington's Disease  
  Beglinger LJ, Langbehn DR, Duff K, Stierman L, Black DW, Nehl C, Anderson KE, et al, Biol Psychiatry, 1/1/2007
• Psychosis in Parkinson's disease: case studies  
  Salter BC, Anderson KE, Weiner WJ, Neurol Clin, 1/1/2006
• American Academy of Neurology Practice Parameter Guidelines Treatment of nonmotor symptoms in Parkinson's disease  
  Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson KE ,et al, Neurology, 1/1/2006
• When do patients with Parkinson disease disclose their diagnosis?  
  Haines S, Chen H, Anderson KE, Fishman PS, Shulman LM, Weiner WJ, Reich SG, Neurology, 1/1/2006
• Subjective report versus objective measurement of activities of daily living in Parkinson's disease  
  Shulman LM, Pretzer-Aboff I, Anderson KE, Stevenson R, Vaughan CG, Gruber-Baldini AL, Reich SG, Weiner WJ, Mov Disord, 1/1/2006
• Join now to see all

Books/Book Chapters

• Parkinson's Disease: Diagnosis and Clinical Management 
  Chapter: Treatment of Dementia 
  Anderson, KEEditors: Stewart Factor, M.D. and William J. Weiner, M.D..Edition 2nd,2007
• Advances in Neurology Series 
  Chapter: Behavioral Neurology of Movement Disorders 
  Anderson KE, Weiner WJ, Lang AE (Editors)Editors: Anderson KE, Weiner WJ, Lang AE.Lippincott, Williams & Wilkins, Philadelphia, PAEdition 2nd,2005
• Psychiatry for Neurologists 
  Chapter: Huntington's Disease 
  Karen E. Anderson, Karen S. Marder2005
• Adv Neurol 
  Chapter: Behavioral symptoms associated with Huntington's disease 
  Page 197 - 208Anderson KE, Marshall FJ2005
• American Psychiatric Association Textbook of Traumatic Brain Injury 
  Chapter: Neuroimaging in Traumatic Brain Injury 
  Karen E. Anderson, Robin Hurley, Katherine TaberEditors: J. Silver and T. McAllister.APA Press2004
• Medical Management of the Violent Patient 
  Chapter: Neurological and Medical Diseases 
  Page 87 - 124Karen Anderson, Jon SilverEditors: Tardiff K.Marcel Decker Press, NY1999
• Current Therapy in Neurologic Disese 
  Chapter: Huntington's Disease 
  Page 282 - 287Karen E. Anderson, Karen MarderEditors: Richard T. Johnson, John W. Griffin, Justin C. McArthur.Edition 6th,
• Handbook of Clinical Neurology on Hyperkinetic Movement Disorders 
  Chapter: Huntington's Disease - Behavioral and Psychiatric Symptoms 
  Anderson, KEEditors: Weiner and Tolosa.
• Join now to see all

Lectures

• Research Update 
  Richmond, VA - 1/1/2013
• Huntington's Study Group Educational Sessions 
  Charlotte, NC - 1/1/2013
• Huntington's Study Group Local Provider Education Program 
  Charlotte, NC - 1/1/2013
• What does Huntington's Disease Teach Us About Behavior 
  University of Maryland - 1/1/2013
• Huntington's Disease Update 
  Walter Reed Army Medical Center - 1/1/2013
• Psychogenic Movement Disorders- Are they Treatable? 
  Dublin, Ireland - 1/1/2012
• Behavioral Changes in Huntington's Disease 
  IN - 1/1/2011
• HD 101: Understanding Huntington's Disease. Treatment Options and Future Trends 
  Washington, DC - 1/1/2010
• Treatment of Behavioral Symptoms in Huntington's Disease 
  La Jolla, CA - 1/1/2010
• Nonpharmacological Treatments for Parkinson's Disease 
  Glasgow, Scotland - 1/1/2010
• Behavioral Symptoms 
  Baltimore, MD - 1/1/2010
• Behavioral Symptoms in Huntington's Disease 
  Albany Medical College - 1/1/2009
• Behavioral Issues in Parkinson's Disease 
  University of Maryland - 1/1/2009
• Early versus Late Onset Huntington's Disease 
  1/1/2009
• Neuropsychiatry of Basal Ganglia Disorders 
  Southern Illinois University - 1/1/2008
• Basal Ganglia Disorders 
  1/1/2007
• Effects of Behavioral Changes on Motor Symptoms and Functional Ability in Parkinson's Disease 
  Washington, DC - 1/1/2006
• Caring for a Patient with Huntington's Disease 
  1/1/2005
• Neuropsychiatric Perspectives on Huntington's Disease 
  University of Maryland - 1/1/2003
• Obsessions and Compulsions in Huntington's Disease: Clinical and Neural Correlates 
  1/1/2002
• Neuropsychiatric Symptoms in Huntington's Disease 
  University of Maryland - 1/1/2002
• Neuropsychiatry of Huntington's Disease 
  Harlem Hospital Center - 1/1/2000
• Join now to see all

Other

• Huntington's Disease and Parkinson's Disease 
  Anderson KE, Maryland Health Today
  1/1/2009